1. Researchers from 437 cancer centers from across the United States are recruiting at least 370 patients with metastatic colorectal cancers to report on the financial hardships brought on by their care.
2. Researchers selected colorectal cancer because patients survive the disease, and could potentially face “mountains” of medical bills.
3. Pharmaceutical companies argue that the high price for new drugs is to recoup development costs, but several critics the prices are “beyond what is necessary.”
4. Researchers are currently in the process of recruiting participants.
More articles on gastroenterology:
Physicians Endoscopy buys into Great South Bay Endoscopy — 4 key notes
Gastro Health acquires Pediatric Gastroenterology Associates — Gastro Health now largest South Florida pediatric GI group
UnitedHealthcare to cover Exact Sciences’ Cologuard — Exact shares jump 12%
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
